Confidence intervals for odds ratio from multistage randomized phase II trials von Cao, Shiwei, Jung, Sin‐Ho

Volltext

Group sequential testing for cluster randomized trials with time‐to‐event endpoint von Li, Jianghao, Jung, Sin‐Ho

Volltext

Sample size calculation for cluster randomization trials with a time‐to‐event endpoint von Li, Jianghao, Jung, Sin‐Ho

Volltext

Sample size calculation for comparing two ROC curves von Jung, Sin‐Ho

Volltext

Estimation of the odds ratio from multi‐stage randomized trials von Cao, Shiwei, Jung, Sin‐Ho

Volltext

Intensive Chemotherapy and Immunotherapy in Patients With Newly Diagnosed Primary CNS Lymphoma: CALGB 50202 (Alliance 50202) von RUBENSTEIN, James L, HSI, Eric D, JOHNSON, Jeffrey L, JUNG, Sin-Ho, NAKASHIMA, Megan O, GRANT, Barbara, CHESON, Bruce D, KAPLAN, Lawrence D

Volltext

Stratified Fisher's exact test and its sample size calculation von Jung, Sin-Ho

Volltext

A Dunnett-Type Test and Its Sample Size Calculation for Comparing K ROC Curves with a Control von Jung, Sin-Ho

Volltext

Diagnostic Performance of an Artificial Intelligence System in Breast Ultrasound von O'Connell, Avice M., Bartolotta, Tommaso V., Orlando, Alessia, Jung, Sin‐Ho, Baek, Jihye, Parker, Kevin J.

Volltext

A prognostic index for natural killer cell lymphoma after non-anthracycline-based treatment: a multicentre, retrospective analysis von Kim, Seok Jin, Prof, Yoon, Dok Hyun, MD, Jaccard, Arnaud, MD, Chng, Wee Joo, MD, Lim, Soon Thye, MD, Hong, Huangming, MD, Park, Yong, MD, Chang, Kian Meng, MD, Maeda, Yoshinobu, MD, Ishida, Fumihiro, Prof, Shin, Dong-Yeop, MD, Kim, Jin Seok, MD, Jeong, Seong Hyun, MD, Yang, Deok-Hwan, MD, Jo, Jae-Cheol, MD, Lee, Gyeong-Won, MD, Choi, Chul Won, Prof, Lee, Won-Sik, MD, Chen, Tsai-Yun, MD, Kim, Kiyeun, Jung, Sin-Ho, PhD, Murayama, Tohru, MD, Oki, Yasuhiro, MD, Advani, Ranjana, MD, d'Amore, Francesco, Prof, Schmitz, Norbert, Prof, Suh, Cheolwon, Prof, Suzuki, Ritsuro, MD, Kwong, Yok Lam, Prof, Lin, Tong-Yu, MD, Kim, Won Seog, Prof

Volltext

Randomised, double-blind, placebo-controlled trial of Probiotics To Eliminate COVID-19 Transmission in Exposed Household Contacts (PROTECT-EHC): a clinical trial protocol von Tang, Helen, Bohannon, Lauren, Lew, Meagan, Jensen, David, Jung, Sin-Ho, Zhao, Aaron, Sung, Anthony D, Wischmeyer, Paul E

Volltext

Optimal designs for phase II clinical trials with heterogeneous patient populations von Liu, Lu, Cao, Shiwei, Jung, Sin-Ho

Volltext

Sinonasal Squamous Cell Carcinoma Outcomes: Does Treatment at a High-Volume Center Confer Survival Benefit? von Teitelbaum, Jordan I., Issa, Khalil, Barak, Ian R., Ackall, Feras Y., Jung, Sin-Ho, Jang, David W., Abi Hachem, Ralph

Volltext

A prediction model for advanced colorectal neoplasia in an asymptomatic screening population von Hong, Sung Noh, Son, Hee Jung, Choi, Sun Kyu, Chang, Dong Kyung, Kim, Young-Ho, Jung, Sin-Ho, Rhee, Poong-Lyul

Volltext

CALGB 50604: risk-adapted treatment of nonbulky early-stage Hodgkin lymphoma based on interim PET von Straus, David J., Jung, Sin-Ho, Pitcher, Brandelyn, Kostakoglu, Lale, Grecula, John C., Hsi, Eric D., Schöder, Heiko, Popplewell, Leslie L., Chang, Julie E., Moskowitz, Craig H., Wagner-Johnston, Nina, Leonard, John P., Friedberg, Jonathan W., Kahl, Brad S., Cheson, Bruce D., Bartlett, Nancy L.

Volltext

Bacteremia in solid organ transplant recipients as compared to immunocompetent patients: Acute phase cytokines and outcomes in a prospective, matched cohort study von Eichenberger, Emily M., Ruffin, Felicia, Dagher, Michael, Lerebours, Reginald, Jung, Sin‐Ho, Sharma‐Kuinkel, Batu, Macintyre, Andrew N., Thaden, Joshua T., Sinclair, Matthew, Hale, Lauren, Kohler, Celia, Palmer, Scott M., Alexander, Barbara D., Fowler, Vance G., Maskarinec, Stacey A.

Volltext

Revisiting flow augmentation bypass for cerebrovascular atherosclerotic vaso-occlusive disease: Single-surgeon series and review of the literature von Abdelgadir, Jihad, Haskell-Mendoza, Aden P, Magno, Amanda R, Suarez, Alexander D, Antwi, Prince, Raghavan, Alankrita, Nelson, Patricia, Yang, Lexie Zidanyue, Jung, Sin-Ho, Zomorodi, Ali R

Volltext

Optimal cut‐off age in the TNM Staging system of differentiated thyroid cancer: is 55 years better than 45 years? von Kim, Mijin, Kim, Young Nam, Kim, Won Gu, Park, Suyeon, Kwon, Hyemi, Jeon, Min Ji, Ahn, Hyeon Seon, Jung, Sin‐Ho, Kim, Sun Wook, Kim, Won Bae, Chung, Jae Hoon, Shong, Young Kee, Kim, Tae Hyuk, Kim, Tae Yong

Volltext

LASSO and Elastic Net Tend to Over-Select Features von Liu, Lu, Gao, Junheng, Beasley, Georgia, Jung, Sin-Ho

Volltext

Phase II clinical trials with time-to-event endpoints: optimal two-stage designs with one-sample log-rank test von Kwak, Minjung, Jung, Sin-Ho

Volltext